European Healthtech startup funding raised during H2 2013.
In H2 2013, 60 European Healthtech companies raised a combined €329M across 62 funding rounds, up 8.8% versus H2 2012. Switzerland led by capital raised, and Bpifrance was the most active investor. Data as of 7 Aug 2026.
| €30M |
| ObsEva | Series A | Aug 2013 | €26M |
| MISSION Therapeutics | Series B | Nov 2013 | €24M |
| WiThings | Series B | Jul 2013 | €23M |
| CeQur | Series B | Sep 2013 | €20M |
| Pixium Vision | Other | Nov 2013 | €15M |
| THERAVECTYS | Other | Oct 2013 | €15M |
| Morria Biopharmaceuticals | Other | Oct 2013 | €11M |
| Gecko Biomedical | Other | Dec 2013 | €9.9M |
| Simplee | Series B | Sep 2013 | €7.6M |
| Egalet | Growth/Late | Sep 2013 | €7.6M |
| Epigenomics AG | Other | Aug 2013 | €5.0M |
